Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Raymond Fong, Megan E Cavet, Heleen H DeCory & Jason L Vittitow. (2019)
Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies. Clinical Ophthalmology 13, pages 1427-1438.
Read now
Read now
JD Sheppard & IP Singh. (2019) Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery. Clinical Ophthalmology 13, pages 1279-1288.
Read now
Read now
Mahmoud A Khaimi. (2018) A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty. Clinical Ophthalmology 12, pages 319-329.
Read now
Read now
Timothy L. Comstock & John D. Sheppard. (2018) Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid. Expert Opinion on Pharmacotherapy 19:4, pages 337-353.
Read now
Read now
Nirav Patel, Happy Nakrani, Mihir Raval & Navin Sheth. (2016) Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability. Drug Delivery 23:9, pages 3712-3723.
Read now
Read now
Clifford L Salinger, Michael Gordon, Mitchell A Jackson, Theodore Perl & Eric Donnenfeld. (2015) A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery. Clinical Ophthalmology 9, pages 2089-2097.
Read now
Read now
Eric D Donnenfeld. (2015) Current trends in postsurgical management of ocular inflammation following cataract surgery. Expert Review of Ophthalmology 10:1, pages 23-31.
Read now
Read now
John D Sheppard, Arnulfo Mansur, Timothy L Comstock & John A Hovanesian. (2014) An update on the surgical management of pterygium and the role of loteprednol etabonate ointment. Clinical Ophthalmology 8, pages 1105-1118.
Read now
Read now
Preeti K Suresh & Abhishek K Sah. (2014) Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions. Expert Opinion on Drug Delivery 11:11, pages 1747-1768.
Read now
Read now
Articles from other publishers (4)
Xi Chen, Shima Gholizadeh, Mahsa Ghovvati, Ziqing Wang, Marcus J. Jellen, Azadeh Mostafavi, Reza Dana & Nasim Annabi. (2023) Engineering a drug eluting ocular patch for delivery and sustained release of anti‐inflammatory therapeutics. AIChE Journal 69:6.
Crossref
Crossref
Antonysamy Dennyson Savariraj, Ahmed Salih, Fahad Alam, Mohamed Elsherif, Bader AlQattan, Ammar A. Khan, Ali K. Yetisen & Haider Butt. (2021) Ophthalmic Sensors and Drug Delivery. ACS Sensors 6:6, pages 2046-2076.
Crossref
Crossref
Mónica Vicente-Pascual, Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Alicia Rodríguez-Gascón, Elisabetta Muntoni, Luigi Battaglia, Ana del Pozo-Rodríguez & María Ángeles Solinís Aspiazu. (2020) Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production. Pharmaceutics 12:6, pages 584.
Crossref
Crossref
Halah Talal Sulaiman & Hanan Jalal Kassab. (2018) PREPARATION AND CHARACTERIZATION OF ECONAZOLE NITRATE INCLUSION COMPLEX FOR OCULAR DELIVERY SYSTEM. International Journal of Applied Pharmaceutics, pages 175-181.
Crossref
Crossref